Robert J. Barnaby

589 total citations
20 papers, 473 citations indexed

About

Robert J. Barnaby is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Robert J. Barnaby has authored 20 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 5 papers in Oncology. Recurrent topics in Robert J. Barnaby's work include Neuroscience and Neuropharmacology Research (7 papers), Drug Transport and Resistance Mechanisms (5 papers) and Phytase and its Applications (4 papers). Robert J. Barnaby is often cited by papers focused on Neuroscience and Neuropharmacology Research (7 papers), Drug Transport and Resistance Mechanisms (5 papers) and Phytase and its Applications (4 papers). Robert J. Barnaby collaborates with scholars based in Italy, United Kingdom and United States. Robert J. Barnaby's co-authors include Paula Grossi, Simone Braggio, C I Ragan, N S Gee, Rosamond G. Jackson, G Reid, R. BAKER, Keith J. Watling, Paul D. Leeson and David C. Billington and has published in prestigious journals such as Analytical Biochemistry, Biochemical Journal and Journal of Medicinal Chemistry.

In The Last Decade

Robert J. Barnaby

20 papers receiving 443 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert J. Barnaby Italy 10 189 65 64 49 46 20 473
Maria Grazia Leone Italy 12 146 0.8× 53 0.8× 48 0.8× 46 0.9× 58 1.3× 35 470
Börje Egestad Sweden 13 162 0.9× 91 1.4× 35 0.5× 56 1.1× 32 0.7× 26 462
H. Bun France 14 180 1.0× 37 0.6× 45 0.7× 28 0.6× 16 0.3× 43 484
Rubén Alvarez‐Sánchez Switzerland 15 294 1.6× 94 1.4× 62 1.0× 46 0.9× 28 0.6× 24 728
Bernard Serkiz France 11 229 1.2× 88 1.4× 53 0.8× 76 1.6× 22 0.5× 15 491
Katja Hempel Germany 7 148 0.8× 27 0.4× 32 0.5× 26 0.5× 29 0.6× 25 465
Yoshiharu Hayashi Japan 13 187 1.0× 70 1.1× 80 1.3× 20 0.4× 92 2.0× 45 528
Kathleen R. Noon United States 13 370 2.0× 53 0.8× 24 0.4× 89 1.8× 37 0.8× 24 705
Munetaka Nokubo Japan 11 398 2.1× 70 1.1× 52 0.8× 36 0.7× 50 1.1× 24 732
Alexander Böcker Germany 14 439 2.3× 54 0.8× 58 0.9× 45 0.9× 89 1.9× 18 736

Countries citing papers authored by Robert J. Barnaby

Since Specialization
Citations

This map shows the geographic impact of Robert J. Barnaby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Barnaby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Barnaby more than expected).

Fields of papers citing papers by Robert J. Barnaby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Barnaby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Barnaby. The network helps show where Robert J. Barnaby may publish in the future.

Co-authorship network of co-authors of Robert J. Barnaby

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Barnaby. A scholar is included among the top collaborators of Robert J. Barnaby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. Barnaby. Robert J. Barnaby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wood, Martyn, et al.. (2015). In Vitro and In Vivo Identification of Novel Positive Allosteric Modulators of the Human Dopamine D2 and D3 Receptor. Molecular Pharmacology. 89(2). 303–312. 20 indexed citations
2.
Roberts, Karen, Antonella Ursini, Robert J. Barnaby, et al.. (2011). Synthesis and structure–activity relationship of new 1,5-dialkyl-1,5-benzodiazepines as cholecystokinin-2 receptor antagonists. Bioorganic & Medicinal Chemistry. 19(14). 4257–4273. 13 indexed citations
3.
Fabio, Romano Di, Giuseppe Alvaro, Barbara Bertani, et al.. (2006). Chiral tetrahydroquinoline derivatives as potent anti-hyperalgesic agents in animal models of sustained inflammation and chronic neuropathic pain. Bioorganic & Medicinal Chemistry Letters. 17(5). 1176–1180. 21 indexed citations
4.
Angusti, Angela, Elisa Durini, Silvia Vertuani, et al.. (2005). Synthesis and biological evaluation of pro-drugs of GW196771, a potent glycine antagonist acting at the NMDA receptor. Il Farmaco. 60(5). 393–397. 3 indexed citations
5.
Polli, Joseph W., Todd M. Baughman, Joan E. Humphreys, et al.. (2004). THE SYSTEMIC EXPOSURE OF AN N-METHYL-d-ASPARTATE RECEPTOR ANTAGONIST IS LIMITED IN MICE BY THE P-GLYCOPROTEIN AND BREAST CANCER RESISTANCE PROTEIN EFFLUX TRANSPORTERS. Drug Metabolism and Disposition. 32(7). 722–726. 20 indexed citations
6.
Fabio, Romano Di, Barbara Bertani, Giuseppe Alvaro, et al.. (2003). Enantiomerically pure tetrahydroquinoline derivatives as in vivo potent antagonists of the glycine binding site associated to the NMDA receptor. Bioorganic & Medicinal Chemistry Letters. 13(21). 3863–3866. 20 indexed citations
7.
Barnaby, Robert J., et al.. (2003). Pharmacokinetics, metabolism and excretion of the glycine antagonist GV150526A in rat and dog. Xenobiotica. 33(4). 415–428. 5 indexed citations
8.
Gilissen, Ron, et al.. (2000). Human hepatic metabolism of a novel 2-carboxyindole glycine antagonist for stroke: invitro-in vivocorrelations. Xenobiotica. 30(9). 843–856. 5 indexed citations
9.
Gilissen, Ron, et al.. (2000). Identification of UDP-Glucuronosyltransferases Involved in the Human Hepatic Metabolism of GV150526, a Novel Glycine Antagonist. Drug metabolism and drug interactions. 16(3). 173–190. 3 indexed citations
10.
Hoke, John F., Alexander Dyker, Robert J. Barnaby, & Kennedy R. Lees. (2000). Pharmacokinetics of a glycine site antagonist (gavestinel) following multiple dosing in patients with acute stroke. European Journal of Clinical Pharmacology. 55(11-12). 867–872. 9 indexed citations
11.
Bordi, Fabio, Manolo Mugnaini, Andrea Terron, Robert J. Barnaby, & Angelo Reggiani. (2000). GV150526: A Neuroprotective Agent. CNS Drug Reviews. 6(2). 135–152. 3 indexed citations
12.
Iavarone, Laura, et al.. (1999). First Time in Human for GV196771: Interspecies Scaling Applied on Dose Selection. The Journal of Clinical Pharmacology. 39(6). 560–566. 21 indexed citations
13.
Fabio, Romano Di, Aldo Feriani, Stefano Provera, et al.. (1999). Substituted Analogues of GV150526 as Potent Glycine Binding Site Antagonists in Animal Models of Cerebral Ischemia. Journal of Medicinal Chemistry. 42(18). 3486–3493. 27 indexed citations
14.
Braggio, Simone, et al.. (1996). A strategy for validation of bioanalytical methods. Journal of Pharmaceutical and Biomedical Analysis. 14(4). 375–388. 158 indexed citations
15.
Barnaby, Robert J.. (1991). Mass assay for inositol 1-phosphate in rat brain by high-performance liquid chromatography and pulsed amperometric detection. Analytical Biochemistry. 199(1). 75–80. 9 indexed citations
16.
Barnaby, Robert J., et al.. (1991). Enantiomeric Separation of Substituted Quinuclidines and Aza-Norbornanes By HPLC Using an Acetylated β-Cyclodextrin Bonded Stationary Phase. Journal of Liquid Chromatography. 14(2). 287–295. 3 indexed citations
17.
Howell, Steven, Robert J. Barnaby, Tony Rowe, C I Ragan, & N S Gee. (1989). Evidence for at least four different inositol bisphosphatases in bovine brain. European Journal of Biochemistry. 183(1). 169–172. 8 indexed citations
18.
Ragan, C I, Keith J. Watling, N S Gee, et al.. (1988). The dephosphorylation of inositol 1,4-bisphosphate to inositol in liver and brain involves two distinct Li+-sensitive enzymes and proceeds via inositol 4-phosphate. Biochemical Journal. 249(1). 143–148. 77 indexed citations
19.
Gee, N S, G Reid, Rosamond G. Jackson, Robert J. Barnaby, & C I Ragan. (1988). Purification and properties of inositol-1,4-bisphosphatase from bovine brain. Biochemical Journal. 253(3). 777–782. 39 indexed citations
20.
Winterbourne, David J., Robert J. Barnaby, P. W. Kent, & Nasi Mian. (1979). Incorporation of N-fluoroacetyl-d-glucosamine into hyaluronate by rabbit tracheal explants in organ culture. Biochemical Journal. 182(3). 707–716. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Grazia Leone Breakdown of academic impact, for papers by Börje Egestad Breakdown of academic impact, for papers by H. Bun Breakdown of academic impact, for papers by Rubén Alvarez‐Sánchez Breakdown of academic impact, for papers by Bernard Serkiz Breakdown of academic impact, for papers by Katja Hempel Breakdown of academic impact, for papers by Yoshiharu Hayashi Breakdown of academic impact, for papers by Kathleen R. Noon Breakdown of academic impact, for papers by Munetaka Nokubo Breakdown of academic impact, for papers by Alexander Böcker
Rankless by CCL
2026